临床药师参与耐碳青霉烯大肠埃希菌并耐甲氧西林表皮葡萄球菌感染患儿的药学监护

方圆; 刘秀梅; 郭倩倩; 苑立博

doi:10.13407/j.cnki.jpp.1672-108X.2020.07.011

您当前的位置：

首页 >

文章列表页 >

临床药师参与耐碳青霉烯大肠埃希菌并耐甲氧西林表皮葡萄球菌感染患儿的药学监护

论著（儿科临床药学） | 更新时间：2022-11-03

- 临床药师参与耐碳青霉烯大肠埃希菌并耐甲氧西林表皮葡萄球菌感染患儿的药学监护
- Pharmaceutical Care for One Child Infected with Carbapene-Resistant Escherichia Coli and Meticillin Resistant Staphylococcus Aureus by Clinical Pharmacists
- 儿科药学杂志 2020年26卷第7期页码：34-37
- 作者机构：
  
  1. 郑州人民医院,河南,郑州,450003
  2. 河南工业大学化学化工与环境学院,河南,郑州,450001
- 作者简介：
- 基金信息：
  
  国家自然科学基金青年科学基金项目,编号21708005
- DOI：10.13407/j.cnki.jpp.1672-108X.2020.07.011
  中图分类号：
- 纸质出版日期：2020，
  
  网络出版日期：2020-7-10，
扫描看全文
方圆, 刘秀梅, 郭倩倩, 等. 临床药师参与耐碳青霉烯大肠埃希菌并耐甲氧西林表皮葡萄球菌感染患儿的药学监护[J]. 儿科药学杂志, 2020,26(7):34-37.

Fang Yuan, Liu Xiumei, Guo Qianqian, et al. Pharmaceutical Care for One Child Infected with Carbapene-Resistant Escherichia Coli and Meticillin Resistant Staphylococcus Aureus by Clinical Pharmacists[J]. 2020,26(7):34-37.
方圆, 刘秀梅, 郭倩倩, 等. 临床药师参与耐碳青霉烯大肠埃希菌并耐甲氧西林表皮葡萄球菌感染患儿的药学监护[J]. 儿科药学杂志, 2020,26(7):34-37. DOI： 10.13407/j.cnki.jpp.1672-108X.2020.07.011.

Fang Yuan, Liu Xiumei, Guo Qianqian, et al. Pharmaceutical Care for One Child Infected with Carbapene-Resistant Escherichia Coli and Meticillin Resistant Staphylococcus Aureus by Clinical Pharmacists[J]. 2020,26(7):34-37. DOI： 10.13407/j.cnki.jpp.1672-108X.2020.07.011.

摘要

目的：探讨临床药师在重症感染患儿抗感染治疗中的作用。方法：临床药师参与1例耐碳青霉烯类大肠埃希菌（CRE）并耐甲氧西林表皮葡萄球菌（MRSE）感染患儿的药学监护，协助医师调整、制定药物治疗方案。结果：临床药师应用专业知识，结合患儿的生理病理情况，利用药物代谢动力学/药物效应动力学（PK/PD）参数优化抗感染治疗方案；患儿感染指标明显好转，病情稳定出院。结论：临床药师可以PK/PD角度作为切入点，将药学理论与临床实践相结合，协助医师制定有效的用药方案，成为治疗团队的重要组成部分。

Abstract

Objective: To investigate the role of clinical pharmacists in anti-infection therapy for children with severe infection. Methods: The clinical pharmacists participated into the pharmaceutical care for one child infected with carbapene-resistant Escherichia coli (CRE) and meticillin resistant Staphylococcus aureus (MRSE)

and assisted the clinicians to adjust and formulate medication regimens. Results: The clinical pharmacists applied professional knowledge

combined with the physiological and pathological conditions of children

and used pharmacokinetics/pharmacokinetics (PK/PD) parameters to optimize the anti-infection treatment regimens. The infection indexes of the child were significantly improved

and the child was discharged steadily. Conclusion: The clinical pharmacists can use the PK/PD parameters as an entry point to integrate pharmacy theory with clinical practice

assist the clinicians in developing the effective medication regimen

and become an important part of the therapeutic team.

关键词

耐碳青霉烯类大肠埃希菌耐甲氧西林表皮葡萄球菌感染药学监护

Keywords

carbapene-resistant Escherichia colmeticillin resistant Staphylococcus aureusnfectionpharmaceutical care

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

1 例肾病综合征合并药物性肝损伤患儿的药学监护

儿童精神类药物中毒的救治及药学监护

临床药师对利妥昔单抗治疗儿童激素依赖型肾病综合征的药学监护

某院新生儿科2019-2021 年多重耐药菌分布及耐药性分析

英夫利昔单抗联合硫唑嘌呤治疗儿童克罗恩病的药学监护